Basaglar and Poor quality sleep - a phase IV clinical study of FDA data

Summary:

Poor quality sleep is reported as a side effect among people who take Basaglar (insulin glargine), especially for people who are female, 60+ old, also take Metformin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Poor quality sleep when taking Basaglar. It is created by eHealthMe based on reports of 19,751 people who have side effects when taking Basaglar from the FDA, and is updated regularly.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

What is Poor quality sleep?

Poor quality sleep is found to be associated with 1,265 drugs and 1,163 conditions by eHealthMe. Check the latest studies of Poor quality sleep.

On Jul, 04, 2026

19,751 people reported to have side effects when taking Basaglar.
Among them, 30 people (0.15%) have Poor quality sleep.

Could Basaglar cause Poor quality sleep?

Among these 30 people:

What is the gender of people who have Poor quality sleep when taking Basaglar? *

female: 56.67 %
male: 43.33 %

What is the age of people who have Poor quality sleep when taking Basaglar? *

What are other drugs people take besides Basaglar? *

Jardiance: 6 people, 20.00%
Metformin: 6 people, 20.00%
Trulicity: 5 people, 16.67%
Fiasp: 4 people, 13.33%
Vitamin D: 4 people, 13.33%
Novolog: 4 people, 13.33%
Januvia: 4 people, 13.33%
Eliquis: 4 people, 13.33%
Hydrocodone Bitartrate And Acetaminophen: 3 people, 10.00%
Losartan Potassium: 3 people, 10.00%

What are other side effects people have besides Poor quality sleep? *

Dizziness: 13 people, 43.33%
Fatigue (feeling of tiredness): 10 people, 33.33%
Hair Loss: 7 people, 23.33%
Blood Glucose Increased: 7 people, 23.33%
Nausea (feeling of having an urge to vomit): 7 people, 23.33%
Anaemia (lack of blood): 6 people, 20.00%
Stress And Anxiety: 6 people, 20.00%
Chest Pain: 6 people, 20.00%
Headache (pain in head): 6 people, 20.00%
Back Pain: 6 people, 20.00%

What are the existing conditions these people have? *

Type 2 Diabetes: 13 people, 43.33%
High Blood Pressure: 4 people, 13.33%
Blood Disorder: 4 people, 13.33%
Asthma: 4 people, 13.33%
Vitamin D Decreased: 3 people, 10.00%
Uterine Leiomyoma (uterine benign tumour derived from smooth muscle): 3 people, 10.00%
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 3 people, 10.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 10.00%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 10.00%
Gastrointestinal Stromal Tumor: 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Basaglar and have Poor quality sleep?

- Check whether Poor quality sleep is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Basaglar:

Basaglar (19,807 reports)

Browse all side effects of Basaglar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Poor quality sleep:

Poor quality sleep (1,265 drugs)

Browse all the conditions that are associated with Poor quality sleep:

Poor quality sleep (1,163 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine (the active ingredients of Basaglar) and Basaglar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.